CDKN2B-AS1 and coronary artery disorder: Most of the 9p21.3 CAD-associated genomic variants are located within ANRIL [7], also, expression of ANRIL has been shown to associated with CAD and MI [8, 9], which makes ANRIL the most robust genetic marker of CAD today.